Literature DB >> 4837137

A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.

J S Kovach, A J Schutt, R G Hahn, R J Reitemeier, C G Moertel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4837137     DOI: 10.1159/000224886

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  2 in total

1.  Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors.

Authors:  N C Munshi; P J Loehrer; S D Williams; C Langefeld; G Sledge; C R Nichols; B J Roth; A Neuman; W B Walsh; L H Einhorn
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

2.  The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna.

Authors:  C Bokemeyer; H J Schmoll; E Ludwig; A Harstrick; T Dunn; J Casper
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.